Alpha Tau Medical Publishes Pooled Analysis Of Alpha DaRT Therapy In Journal *Cancers*; Data From 4 International Trials Show Nearly 100% Overall Response Rate And 89% Complete Response Rate In Treated Lesions
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
H.C. Wainwright analyst Yi Chen maintains $Alpha Tau Medical(DRTS.US)$ with a buy rating, and maintains the target price at $9.According to TipRanks data, the analyst has a success rate of 27.0% and a
Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Alpha Tau to Present at the Jefferies Global Healthcare Conference
6-K: Report of foreign private issuer (related to financial reporting)
Press Release: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
HC Wainwright & Co. : The Alpha Tau Medical (DRTS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $9.00.
HC Wainwright & Co. : The Alpha Tau Medical (DRTS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $9.00.
Alpha Tau Treats First Patient With Liver Cancer Metastases Treated In Study Of Alpha DaRT
Alpha Tau Announces Alpha DaRT Treatment of First Patient With Liver Metastases of Colorectal Cancer
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect In Pancreatic Murine Tumor Models At ESTRO 2024 Congress In Glasgow; Initial Data Demonstrates Reduction In Distant Pancreatic Cancer Tumor Growth Rate Starting From 3-Weeks...
Alpha Tau to Participate in May Investor Conferences
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
Buy Rating Affirmed: Anticipating Alpha Tau Medical's Clinical Milestones and Growth Potential in 2024
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Piper Sandler
Piper Sandler Reiterates Overweight on Alpha Tau Medical, Lowers Price Target to $7
Alpha Tau Medical Ltd (DRTS) Gets a Buy From Piper Sandler
Alpha Tau Medical GAAP EPS of -$0.42
Press Release: Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference